Diabetic Peripheral Neuropathy (DPN) refers to a series of clinical symptoms resulting from the symptom-complex of excessive eating for a long time, a deficiency of qi, blood and body fluids, and blocked body channels. According to the theories of traditional Chinese medicine, the qi, blood and body fluids comes from the same source. Qi can not only generate body fluids, but can also promote the activity of body fluids and circulation of blood. Meanwhile, qi is also the fundamental substance constituting and maintaining the living activities of a human body. Therefore, treatment of DPN should focus on boosting qi, nourishing yin, as well as activating qi and promoting the circulation of blood. Clinically, treatment and diagnosis of DPN need to be considered in combination with other symptoms, with comprehensive analysis conducted on the basis of the four diagnostic examination methods.

Jiaru Xu, Yuhong Duan. Treating diabetic peripheral neuropathy from "Qi". International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 4: 16-21. https://doi.org/10.25236/IJFM.2023.050404.

[1] SUN Wenjie, ZHAO Nengjiang, LI Bo, DAI Chunmei, YANG Shuyu. Review of Recommended Chinese Patent Medicines in Guideline for the Prevention and Treatment of Type 2 Diabetes Mellitus in China(2020 Edition) [J]. Chinese Journal of Information on Traditional Chinese Medicine, 2022, 29(3):1-5.

[2] Shabeeb D, Najafi M, Hasanzadeh G, et al. Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review[J]. Diabetes Metab Syndr, 2018, 12(4):591-600.

[3] Tesfaye, Selvarajah. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J]. Diabetes/metabolism research and reviews. 2012, 28(Suppl.1):8-14.

[4] Neurologic Complications Group, Diabetes Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of diabetic neuropathy (2021 edition)[J]. Chinese Journal of Diabetes, 2021, 13(06):540-557.

[5] Wang Xiuge, Ni Qing, Pang Guoming. Guidelines for Diagnosis and Treatment of Diabetic Peripheral Neuropathy based on Combination of Disease and Syndromes [J]. Journal of Traditional Chinese Medicine, 2021, 62(18):1648-1656.

[6] MA Yanchun, HU Jianhui, WU Wenxuan, DUAN Ying, FAN Chuchen, FENG Tiantian, WANG Xu, WU Xiuhong. Research Progress on Chemical Constituents and Pharmacological Effects of Radix Astragali [J]. Acta Chinese Medicine and Pharmacology, 2022, 50(4):92-95.

[7] Zhu Hua, Qin Li, Du Peilin et al. Research progress of pharmacological activity and clinical application of Cassia twig [J]. Chinese Journal of Ethnic and Folk Medicine, 2017,26(22):61-65.

[8] ZHANG Yanli, TIAN Yuan, FU Qifeng, MENG Fanjia, WU Lihong, XU Shujun, KANG Yuhong, ZHANG Xiaojuan. Research Progress of Chemical Constituents and Pharmacological Action of Paeonia tactilora Pall [J]. Acta Chinese Medicine and Pharmacology, 2021, 49(2):104-109.

[9] DENG Cheng-jie, LIU Shuang, XU Xiao-yun, REN Ya-nan, ZHOU Xue-gang, WEI Dong-hua, XIN Ping, SUN Shi-qin. Research Progress on Chemical Constituents and Pharmacological Effects of Sappan lignum [J]. Modern Chinese Medicine, 2020, 22(5):810-826.

[10] Tesfaye S. Recent advances in the management of diabetic distal symmetrical polyneuropathy[J]. Journal of diabetes investigation, 2011, 2(1): 33-42.